Skip to main content
SpringerLink
Log in

Modified antisense oligodeoxynucleotides against the splice acceptor site of tat do not inhibit in vitro hematopoietic colony growth in HIV-positive patients

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

The hematopoietic failure in the majority of patients with progressive HIV infection is further aggravated by virustatic agents like azidothymidine. As an alternative therapeutic attempt, three derivatives of an antisense oligodeoxynucleotide (ODN) against the splice acceptor site of the tat gene have been shown to inhibit HIV replication in vitro. This study was aimed at examining whether these agents are toxic to the hematopoietic progenitor cells. To this end, bone marrow cells from HIV-positive and healthy persons were depleted from adherent cells to eliminate fibroblasts. In further experiments, the cells were additionally enriched for CD34-positive hematopoietic progenitor cells or were depleted fromδTCS-1-positive T lymphocytes. At concentrations of 1.25–10 ΜM, the three antisense ODN did not inhibit any erythrocyte or granulocyte-monocyte colony growth from CD34-positive cells, either from the HIV-positive or from the HIV-negative cohort. In contrast to azidothymidine, which served as inhibitory control, a significant increase of colony growth was seen after depletion of fibroblasts, ofδTCS-1-positive cells, or without cell separation. In conclusion, the three oligodeoxynucleotides do not exert any hematotoxic effect but do increase colony formation from low-density bone marrow cells in vitro and could therefore be useful in future clinical studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zon LI, Groopman JE (1988) Hematologic manifestations of the human immunodeficiency virus (HIV). Semin Hematol 25:208–218

    PubMed  Google Scholar 

  2. Ganser A, Ottmann OG, von Briesen H, Völkers B, Rübsamen-Waigmann H, Hoelzer D (1990) Changes in the haematopoietic progenitor cell compartment in the acquired immunodeficiency syndrome. Res Virol 141:185–193

    PubMed  Google Scholar 

  3. Mitsuya H, Broder S (1987) Strategies for antiretroviral therapy in AIDS. Nature 325:773–778

    PubMed  Google Scholar 

  4. Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT, Jackson GG, Durack DT, Phil D, King D, AZT Collaborative Working Group (1987) The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 317:185–191

    PubMed  Google Scholar 

  5. Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS, Jackson GG, Durack DT, Phil D, Nusinoff-Lehrman S, AZT Collaborative Working Group (1987) The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 317:192–197

    PubMed  Google Scholar 

  6. Sommadossi JP, Carlisle R (1987) Toxicity of 3′-azido-3′deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro. Antimicrob Agents Chemother 31:452–454

    PubMed  Google Scholar 

  7. Daniak N, Worthington M, Riordan MA, Kreczko S, Goldman L (1988) 3′-Azido-3′-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. Br J Haematol 69:299–304

    PubMed  Google Scholar 

  8. Ganser A, Greher J, Völkers B, Staszeweski S, Hoelzer D (1989) Inhibitory effect of azidothymidine, 2′-3′-dideoxyadenosine, and 2′-3′-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS. Exp Hematol 17:321–325

    PubMed  Google Scholar 

  9. Yarchoan R, Klecker RW, Weinhold KJ, Markham PD, Lyerly HK, Durack DT, Gelmann E, Nusinoff-Lehrman S, Blum RM, Barry DW (1986) Administration of 3′-azido-3′-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet 1:575

    PubMed  Google Scholar 

  10. Walker BD, Kowalski M, Goh WC, Kozarsky K, Krieger M, Rosen C, Rohrschneider L, Haseltine WA, Sodroski J (1987) Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine. Proc Natl Acad Sci USA 84:8120–8124

    PubMed  Google Scholar 

  11. Schröder HC, Wenger R, Rottmann M, Müller WEG (1988) Alteration of nuclear (2′-5′)oligoriboadenylate synthetase and nuclease activities preceding replication of human immunodeficiency virus in H9 cells. Biol Chem Hoppe Seyler 369:985–995

    PubMed  Google Scholar 

  12. Schröder HC, Wenger R, Kuchino Y, Müller WEG (1989) Modulation of nuclear matrix-associated (2′-5′)oligoadenylate metabolism and ribonuclease L activity in H9 cells by human immunodeficiency virus. J Biol Chem 264:5669–5673

    PubMed  Google Scholar 

  13. Montefiori DC, Sobol RW, Li SW, Reichenbach NL, Suhadolnik RJ, Charubala R, Pfleiderer W, Modliszewski A, Robinson WE, Mitchell WM (1989) Phosphorothioate and cordycepin analogous of 2′,5-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro. Proc Natl Acad Sci USA 86:7191–7194

    PubMed  Google Scholar 

  14. Renneisen K, Leserman L, Matthes E, Schröder HC, Müller WEG (1990) Inhibition of expression of human immunodeficiency virus-1 in vitro by antibody-targeted liposomes containing antisense RNA to the env region. J Biol Chem 265:16337–16342

    PubMed  Google Scholar 

  15. Goodchild J, Agrawal S, Civeira MP, Sarin PS, Sun D, Zamechnik PC (1988) Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 85:5507–5511

    PubMed  Google Scholar 

  16. Matsukura M, Zon G, Shinozuka K, Robert-Guroff M, Shimada T, Stein CA, Mitsuya H, Wong-Staal F, Cohen JS, Broder S (1989) Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells. Proc Natl Acad Sci USA 86:4244–4248

    PubMed  Google Scholar 

  17. Zauli G, Davis BR, Re MC, Visani G, Furlini G, La Placa M (1992) tat Protein stimulates production of transforming growth factor-Β1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 80:3036–3043

    PubMed  Google Scholar 

  18. Viscidi RP, Mayur K, Lederman HM, Frankel AD (1989) Inhibition of antigen-induced lymphocyte proliferation by tat protein from HIV-1. Science 246:1606–1608

    PubMed  Google Scholar 

  19. Ensoli B, Barillari G, Zaki Salahuddin S, Gallo RC, WongStaal F (1990) Protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345:84–86

    PubMed  Google Scholar 

  20. Majumdar C, Stein C, Cohen J, Broder S, Wilson S (1989) HIV reverse transcriptase stepwise mechanism: phosphorothioate oligodeoxynucleotide as primer. Biochemistry 28:1340–1346

    PubMed  Google Scholar 

  21. Stein C, Neckers L, Nair B, Mumbauer S, Hoke G, Pal R (1991) Phosphorothioate oligodeoxynucleotide interferes with binding of CD4 to gp 120. J AIDS 4:686–693

    Google Scholar 

  22. Geissler RG, Ottmann OG, Kleiner K, Mentzel U, Bickelhaupt A, Hoelzer D, Ganser A (1993) Decreased hematopoietic colony growth in long-term bone marrow cultures of HIV-positive patients. Res Virol 144:69–73

    PubMed  Google Scholar 

  23. Geissler RG, Ganser A, Rossol R, Ottmann OG, Klein AS, Mentzel U, Hoelzer D (1992) Inhibition of bone marrow-derived hematopoietic colony formation by a delta-TCS-positive gamma-delta-T-cell-population in patients with AIDS. Exp Hematol 20:733

    Google Scholar 

  24. Ratner L, Haseltine W, Patarca R, Lidvak KJ, Stracich B, Josephs SF, Doran ER, Rafalski JA, Whitehorn EA, Baumeister K, Ivanoff L, Petteway SR, Pearson ML, Lautenberger JA, Papas TS, Ghrayeb J, Chang NT, Gallo RC, Wong-Staal F (1985) Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313:277–284

    PubMed  Google Scholar 

  25. Stein CA, Subasinge C, Shinozuka K, Cohen JS (1988) Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res 16:3209–3221

    PubMed  Google Scholar 

  26. Letsinger RL, Zhang GR, Sun DK, Ikeuchi T, Sarin PS (1989) Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inihibitors of replication of human immunodeficiency virus in cell culture. Proc Natl Acad Sci 86:6553–6556

    PubMed  Google Scholar 

  27. Mag M, Muth J, Lücking S, Bliesert L, Engels J (1991) HIV inhibition by antisense oligodeoxynucleotides. Nucleosides Nucleotides 10:627–629

    Google Scholar 

  28. Agrawal S, Ikeuchi T, Sun D, Sarin PS, Konopka A, Maizel J, Zamechnik PC (1989) Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogs. Proc Natl Acad Sci USA 86:7790–7794

    PubMed  Google Scholar 

  29. Uhlmann E, Peyman A (1990) Antisense oligonucleotides: a new therapeutic principle. Chem Rev 90:543–584

    Google Scholar 

  30. Stein CA (1992) Antisense oligodeoxynucleotides — promises and pitfalls. Leukemia 10:967–974

    Google Scholar 

  31. Ottmann OG, Pelus LM (1988) Differential proliferative effects of transforming growth factor-Β on human hematopoietic progenitor cells. J Immunol 140:2661–2665

    PubMed  Google Scholar 

  32. Ganser A, Carlo-Stella C, Greher J, Völkers B, Hoelzer D (1987) Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells. Blood 70:1173–1179

    PubMed  Google Scholar 

  33. Louache F, Henri A, Bettaieb A, Oksenhendler E, Raguin G, Tulliez M, Vainchenker W (1992) Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 80:2991–2999

    PubMed  Google Scholar 

  34. Chang HK, Gendelman R, Lisziewicz J, Gallo RC, Ensoli B (1994) Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1. Gene Ther 1:208–216

    PubMed  Google Scholar 

  35. Lisziewicz J, Sun D, Metelev, Zamecnik P, Gallo RC, Agrawal S (1993) Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucletide phosphorothiates. Proc Natl Acad Sci USA 90:3860–3864

    PubMed  Google Scholar 

  36. Kim SG, Suzuki Y, Nakashima H, Yamamoto N, Takaku H (1991) Phosphorothioate analogs of oligodeoxyribonucleotide: synthesis and activity as inhibitors of replication of human immunodeficiency virus. Biochem Biophys Res Commun 179:1614–1619

    PubMed  Google Scholar 

  37. Iversen PL, Crouse D, Zon G, Perry G (1992) Binding of antisense phosphorothioate oligonucleotides to murine lymphocytes is lineage specific and inducible. Antisense Res Dev 223–233

  38. Laurence J, Sikder SK, Kulkosky J, Miller P, Ts'o PO (1993) Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphanate oligodeoxynucleoside targeted to a U3 enhancer element. J Virol 65:213–219

    Google Scholar 

  39. Balotta C, Lusso P, Crowley R, Gallo RC, Franchini G (1993) Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages. J Virol 67:4409–4414

    PubMed  Google Scholar 

  40. Bordier B, Helene C, Barr PJ, Litvak S, Sarih-Cottin L (1992) In vitro effects of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcriptase. Nucleic Acids Res 20:5999–6006

    PubMed  Google Scholar 

  41. Stein CA, Cheng YC (1993) Antisense oligonucleotides as therapeutic agents — is the bullet really magical? Science 261:1004–1012

    PubMed  Google Scholar 

  42. Maury G, El Alaoui A, Morvan F, Müller B, Imbach JL, Goody RS (1992) Template. Phosphorothioate oligonucleotide duplexes as inhibitors of HIV-1 reverse transcriptase. Biochem Biophys Res Commun 186:1249–1256

    PubMed  Google Scholar 

  43. Morvan F, Porumb H, Degols G, Lefebvre I, Pompon A, Sproat BS, Rayner B, Malvy C, Lebleu B, Imbach JL (1993) Comparative evaluation of seven oligonucleotide analogues as potential antisense agents. J Med Chem 36:280–287

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, University of Frankfurt/Main, Theodor-Stern-Kai 7, D-60590, Frankfurt/M., Germany

    R. G. Geissler, A. Maurer, U. Mentzel, D. Hoelzer & A. Ganser

  2. Institute of Organic Chemistry, University of Frankfurt/Main, D-60439, Frankfurt/M., Germany

    J. Muth, M. Mag & J. W. Engels

Authors
  1. R. G. Geissler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Muth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Maurer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. Mentzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Mag
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. W. Engels
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Hoelzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Ganser
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Geissler, R.G., Muth, J., Maurer, A. et al. Modified antisense oligodeoxynucleotides against the splice acceptor site of tat do not inhibit in vitro hematopoietic colony growth in HIV-positive patients. Ann Hematol 71, 89–95 (1995). https://doi.org/10.1007/BF01699252

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01699252

Key words

Search

Navigation